13073_2022_1060_MOESM1_ESM.xlsx (17.46 kB)

Additional file 1 of Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma

dataset

posted on 2022-05-31, 08:46 authored by Jenette Creaney, Ann-Marie Patch, Venkateswar Addala, Sophie A. Sneddon, Katia Nones, Ian M. Dick, Y. C. Gary Lee, Felicity Newell, Ebony J. Rouse, Marjan M. Naeini, Olga Kondrashova, Vanessa Lakis, Apostolos Nakas, David Waller, Annabel Sharkey, Pamela Mukhopadhyay, Stephen H. Kazakoff, Lambros T. Koufariotis, Aimee L. Davidson, Priya Ramarao-Milne, Oliver Holmes, Qinying Xu, Conrad Leonard, Scott Wood, Sean M. Grimmond, Raphael Bueno, Dean A. Fennell, John V. Pearson, Bruce W. Robinson, Nicola Waddell

Additional file 1: Table S1. Clinical characteristics of the MPM samples that underwent whole genome sequencing

Funding

National Health and Medical Research Council Australian Government Research Training Program QIMR Berghofer Medical Research Institute Ian Potter Foundation The John Thomas Wilson Endowment Estate of Mr Stewart Coggins

History

Usage metrics

Keywords

Malignant pleural mesothelioma Whole genome sequencing RNA sequencing Mutational signatures Tumour micro-environment Immunotherapy

Licence

CC BY + CC0